ARCHIVES

In Brief: Megastrol Acetate Still Under FDA Review; Mays Hired For NCI’s Technology Office

This article is from The Cancer Letter archive.

Vol. 16 No. 29 | July 20, 1990

Download PDF Visit The Full Archive

Related Articles

Nexavar Phase III Trial Fails To Meet Primary Endpoint

June 29, 2012

Foon Moves To UPCI

April 18, 2003

NCI’s Drug Screen Tests 400 Agents A Week; Recompetition Of Contracts Approved

February 26, 1993

MammoSite Radiation System Delivers Dose To Target Tissue

February 28, 2003

NCI Study Says 2 Million US Women Could Benefit from Tamoxifen

April 11, 2003

Three cancer centers joined the Multiple Myeloma Research Consortium.

September 16, 2005